Schedule 13G ownership disclosure

AMAG PHARMACEUTICALS INC.

Security class unavailable · CUSIP: 00163U106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,795,233
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001421578-16-000051
Form type
SC 13G/A
Filer
AMAG PHARMACEUTICALS, INC.
CIK
CIK 792977
Filed
Feb 16, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub